Trial Profile
Phase 2 clincal trial of cridanimod (Virexxa) for treatment of endometrial cancer in the Russian Federation
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 19 Jul 2013
Price :
$35
*
At a glance
- Drugs Cridanimod (Primary)
- Indications Endometrial cancer
- Focus Adverse reactions; Pharmacodynamics
- 19 Jul 2013 New trial record